BSLN.SW
Price:
$42.9
Market Cap:
$520.00M
Basilea Pharmaceutica AG, a commercial stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. It offers Cresemba, an intravenous and oral azole antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union, as well as in Phase III clinical trials for invasive fungal infections in Japan. The company also provides Zevtera, an antibiotic for the treatment of community and hospital-acquired pneumonia, as well as in Phase III clinical trials for the treatment of acute bacterial skin and skin structure infections, and Staphylococcus a...[Read more]
Industry
Biotechnology
IPO Date
2004-03-25
Stock Exchange
SIX
Ticker
BSLN.SW
According to Basilea Pharmaceutica AG’s latest financial reports and current stock price. The company's current Current Ratio is 4.10. This represents a change of 32.26% compared to the average of 3.10 of the last 4 quarters.
The mean historical Current Ratio of Basilea Pharmaceutica AG over the last ten years is 3.49. The current 4.10 Current Ratio has changed 11.67% with respect to the historical average. Over the past ten years (40 quarters), BSLN.SW's Current Ratio was at its highest in in the June 2011 quarter at 6.56. The Current Ratio was at its lowest in in the January 2009 quarter at 0.
Average
3.49
Median
3.68
Minimum
1.38
Maximum
5.59
Discovering the peaks and valleys of Basilea Pharmaceutica AG Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 81.98%
Maximum Annual Current Ratio = 5.59
Minimum Annual Increase = -68.98%
Minimum Annual Current Ratio = 1.38
Year | Current Ratio | Change |
---|---|---|
2023 | 3.20 | 36.45% |
2022 | 2.34 | 69.50% |
2021 | 1.38 | -68.98% |
2020 | 4.46 | 81.98% |
2019 | 2.45 | -40.57% |
2018 | 4.12 | 11.78% |
2017 | 3.69 | 0.09% |
2016 | 3.68 | -34.14% |
2015 | 5.59 | 41.03% |
2014 | 3.96 | -16.45% |
The current Current Ratio of Basilea Pharmaceutica AG (BSLN.SW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
2.31
5-year avg
2.77
10-year avg
3.49
Basilea Pharmaceutica AG’s Current Ratio is greater than Santhera Pharmaceuticals Holding AG (0.63), greater than Idorsia Ltd (0.63), less than Molecular Partners AG (14.33), less than Evolva Holding SA (8.91), less than Cosmo Pharmaceuticals N.V. (4.85),
Company | Current Ratio | Market cap |
---|---|---|
0.63 | $104.84M | |
0.63 | $166.10M | |
14.33 | $204.53M | |
8.91 | $6.71M | |
4.85 | $1.05B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Basilea Pharmaceutica AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Basilea Pharmaceutica AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Basilea Pharmaceutica AG's Current Ratio?
How is the Current Ratio calculated for Basilea Pharmaceutica AG (BSLN.SW)?
What is the highest Current Ratio for Basilea Pharmaceutica AG (BSLN.SW)?
What is the 3-year average Current Ratio for Basilea Pharmaceutica AG (BSLN.SW)?
What is the 5-year average Current Ratio for Basilea Pharmaceutica AG (BSLN.SW)?
How does the current Current Ratio for Basilea Pharmaceutica AG (BSLN.SW) compare to its historical average?